850398 | 22:1 (Cis) PC
1,2-dierucoyl-sn-glycero-3-phosphocholine

22:1 (Cis) PC
1,2-dierucoyl-sn-glycero-3-phosphocholine
The list of Phosphatidylcholine products offered by Avanti is designed to provide compounds having a variety of physical properties. Products available include short chain (C3-C8 are water soluble and hygroscopic), saturated, multi-unsaturated and mixed acid PC's. All of the products are purified by HPLC, and special precautions are taken to protect the products from oxidization and hydrolysis. Several of these products are manufactured under the current guidelines of Good Manufacturing Practice and are available for pharmaceutical use. If you have a requirement for a choline derivative not found on our list, please call us: custom synthesis is one of our specialties.
CAS Registry Number is a Registered Trademark of the American Chemical Society
PC(22:1(13Z)/22:1(13Z))
DEPC
- ChemDraw File
- 3D Structure
- Structure
- Safety Data Sheet
- Safety Data Sheet
- Certificate of Analysis (Lot No. 850398C-25MG-A-042 and 5668CJA042)
- Certificate of Analysis (Lot No. 850398P-25MG-A-042 and 5668PJA042)
- Certificate of Analysis (Lot No. 850398P-25MG-B-042 and 5668PJB042)
- Certificate of Analysis (Lot No. 850398P-25MG-A-044 and 5668PJA044)
- Certificate of Analysis (Lot No. 850398C-25MG-A-044 and 5668CJA044)
- Certificate of Analysis (Lot No. 850398P-25MG-B-044 and 5668PJB044)
- Certificate of Analysis (Lot No. 850398P-25MG-C-044 and 5668PJC044)
- Certificate of Analysis (Lot No. 850398C-25MG-B-044 and 5668CJB044)
- Certificate of Analysis (Lot No. 850398C-25MG-C-044 and 5668CJC044)
- Certificate of Analysis (Lot No. 850398C-25MG-D-044 and 5668CJD044)
- Certificate of Analysis (Lot No. 850398C-25MG-E-044 and 5668CJE044)
- Certificate of Analysis (Lot No. 850398C-25MG-A-051 and 5668CJA051)
Greathouse D, Lipinski K, McKay MJ, Afrose F, Martfeld AN, Koeppe RE 2nd. Influence of Lipid Saturation, Hydrophobic Length and Cholesterol on Double-Arginine-Containing Helical Peptides in Bilayer Membranes. Chembiochem. 2019 May 31. doi: 10.1002/cbic.201900282. [Epub ahead of print]
PubMed ID: 31150136Holopainen M, Colas RA, Valkonen S, Tigistu-Sahle F, Hyvärinen K, Mazzacuva F, Lehenkari P, Käkelä R, Dalli J, Kerkelä E, Laitinen S. Polyunsaturated fatty acids modify the extracellular vesicle membranes and increase the production of proresolving lipid mediators of human mesenchymal stromal cells. Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Jun 15;1864(10):1350-1362. doi: 10.1016/j.bbalip.2019.06.010. [Epub ahead of print]
PubMed ID: 31207356Gutzeit VA, Thibado J, Stor DS, Zhou Z, Blanchard SC, Andersen OS, Levitz J. Conformational dynamics between transmembrane domains and allosteric modulation of a metabotropic glutamate receptor. Elife. 2019 Jun 7;8. pii: e45116. doi: 10.7554/eLife.45116.
PubMed ID: 31172948Forest A, Ruiz M, Bouchard B, Boucher G, Gingras O, Daneault C, Robillard Frayne I, Rhainds D, Consortium TI, Genetics Consortium TNI, Tardif JC, Rioux JD, Des Rosiers C. A Comprehensive and Reproducible Untargeted Lipidomic Workflow Using LC-QTOF Validated for Human Plasma Analysis. J Proteome Res. 2018 Sep 26. doi: 10.1021/acs.jproteome.8b00270. [Epub ahead of print]
PubMed ID: 30256116